Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles

Somvadee Laohavaleeson1, Karen Lolans2,3, John P Quinn2,3,4, Joseph L Kuti1, David P Nicolau11Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA; 2John Stroger Hospital, Chicago, IL, USA; 3Chicago Infectious Disease Research Institute, Chicago, IL, USA; 4Rush Un...

Full description

Bibliographic Details
Main Authors: Somvadee Laohavaleeson, Karen Lolans, John P Quinn, Joseph L Kuti, David P Nicolau
Format: Article
Language:English
Published: Dove Medical Press 2008-11-01
Series:Infection and Drug Resistance
Online Access:http://www.dovepress.com/expression-of-the-mexxy-oprm-efflux-system-in-empseudomonas-aeruginosa-a2617
_version_ 1818155130448510976
author Somvadee Laohavaleeson
Karen Lolans
John P Quinn
Joseph L Kuti
David P Nicolau
author_facet Somvadee Laohavaleeson
Karen Lolans
John P Quinn
Joseph L Kuti
David P Nicolau
author_sort Somvadee Laohavaleeson
collection DOAJ
description Somvadee Laohavaleeson1, Karen Lolans2,3, John P Quinn2,3,4, Joseph L Kuti1, David P Nicolau11Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA; 2John Stroger Hospital, Chicago, IL, USA; 3Chicago Infectious Disease Research Institute, Chicago, IL, USA; 4Rush University Medical Center, Chicago, IL, USAAbstract: While MIC distributions and percent susceptibility for cefepime and ceftazidime are generally similar among Pseudomonas aeruginosa, we noted an increasing discordance in susceptibility favoring ceftazidime at our hospital. Quantitative reverse transcriptase-polymerase chain reaction was utilized to explore overexpression of the MexXY-OprM efflux as the mechanism for this phenotype profile. Thirteen of 15 (87%) randomly selected isolates had mexY gene expression levels of 5.8–40.8-fold relative to the wild-type reference strain. While mexY overexpression was noted in the majority of isolates, other resistance mechanisms appear to contribute to the observed phenotypic profile of the Pseudomonas aeruginosa studied. Clinicians must understand not only the magnitude of difference in the MIC profiles between agents, but also the mechanism(s) responsible for these observations if strategies (ie, pharmacodynamic dosing) are to be designed to optimize patient care outcomes in the face of increasing resistance.Keywords: Pseudomonas aeruginosa, efflux, MexXY-OprM, mexY, cefepime, resistance
first_indexed 2024-12-11T14:37:31Z
format Article
id doaj.art-fcf307b76a4d48128720a783e919de6e
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-11T14:37:31Z
publishDate 2008-11-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-fcf307b76a4d48128720a783e919de6e2022-12-22T01:02:07ZengDove Medical PressInfection and Drug Resistance1178-69732008-11-012008default5155Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profilesSomvadee LaohavaleesonKaren LolansJohn P QuinnJoseph L KutiDavid P NicolauSomvadee Laohavaleeson1, Karen Lolans2,3, John P Quinn2,3,4, Joseph L Kuti1, David P Nicolau11Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA; 2John Stroger Hospital, Chicago, IL, USA; 3Chicago Infectious Disease Research Institute, Chicago, IL, USA; 4Rush University Medical Center, Chicago, IL, USAAbstract: While MIC distributions and percent susceptibility for cefepime and ceftazidime are generally similar among Pseudomonas aeruginosa, we noted an increasing discordance in susceptibility favoring ceftazidime at our hospital. Quantitative reverse transcriptase-polymerase chain reaction was utilized to explore overexpression of the MexXY-OprM efflux as the mechanism for this phenotype profile. Thirteen of 15 (87%) randomly selected isolates had mexY gene expression levels of 5.8–40.8-fold relative to the wild-type reference strain. While mexY overexpression was noted in the majority of isolates, other resistance mechanisms appear to contribute to the observed phenotypic profile of the Pseudomonas aeruginosa studied. Clinicians must understand not only the magnitude of difference in the MIC profiles between agents, but also the mechanism(s) responsible for these observations if strategies (ie, pharmacodynamic dosing) are to be designed to optimize patient care outcomes in the face of increasing resistance.Keywords: Pseudomonas aeruginosa, efflux, MexXY-OprM, mexY, cefepime, resistancehttp://www.dovepress.com/expression-of-the-mexxy-oprm-efflux-system-in-empseudomonas-aeruginosa-a2617
spellingShingle Somvadee Laohavaleeson
Karen Lolans
John P Quinn
Joseph L Kuti
David P Nicolau
Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
Infection and Drug Resistance
title Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
title_full Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
title_fullStr Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
title_full_unstemmed Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
title_short Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles
title_sort expression of the mexxy oprm efflux system in pseudomonas aeruginosa with discordant cefepime ceftazidime susceptibility profiles
url http://www.dovepress.com/expression-of-the-mexxy-oprm-efflux-system-in-empseudomonas-aeruginosa-a2617
work_keys_str_mv AT somvadeelaohavaleeson expressionofthemexxyoprmeffluxsysteminpseudomonasaeruginosawithdiscordantcefepimeceftazidimesusceptibilityprofiles
AT karenlolans expressionofthemexxyoprmeffluxsysteminpseudomonasaeruginosawithdiscordantcefepimeceftazidimesusceptibilityprofiles
AT johnpquinn expressionofthemexxyoprmeffluxsysteminpseudomonasaeruginosawithdiscordantcefepimeceftazidimesusceptibilityprofiles
AT josephlkuti expressionofthemexxyoprmeffluxsysteminpseudomonasaeruginosawithdiscordantcefepimeceftazidimesusceptibilityprofiles
AT davidpnicolau expressionofthemexxyoprmeffluxsysteminpseudomonasaeruginosawithdiscordantcefepimeceftazidimesusceptibilityprofiles